These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28533055)

  • 1. High ASMA
    Amornsupak K; Jamjuntra P; Warnnissorn M; O-Charoenrat P; Sa-Nguanraksa D; Thuwajit P; Eccles SA; Thuwajit C
    Clin Breast Cancer; 2017 Oct; 17(6):441-452.e2. PubMed ID: 28533055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
    Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
    BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of HMGB1/RAGE protein in renal carcinoma and its clinical significance.
    Qie GQ; Wang CT; Chu YF; Wang R
    Int J Clin Exp Pathol; 2015; 8(6):6262-8. PubMed ID: 26261503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGB1-activated fibroblasts promote breast cancer cells metastasis via RAGE/aerobic glycolysis.
    Chen Y; Cai L; Guo X; Li Z; Liao X; Zhang X; Huang L; He J
    Neoplasma; 2021 Jan; 68(1):71-78. PubMed ID: 33030958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Influence of Tumor Stroma on Breast Cancer Subtypes.
    Cid S; Eiro N; Fernández B; Sánchez R; Andicoechea A; Fernández-Muñiz PI; González LO; Vizoso FJ
    Clin Breast Cancer; 2018 Feb; 18(1):e123-e133. PubMed ID: 28927692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
    Merkin RD; Vanner EA; Romeiser JL; Shroyer ALW; Escobar-Hoyos LF; Li J; Powers RS; Burke S; Shroyer KR
    Hum Pathol; 2017 Apr; 62():23-32. PubMed ID: 27816721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells.
    Amornsupak K; Insawang T; Thuwajit P; O-Charoenrat P; Eccles SA; Thuwajit C
    BMC Cancer; 2014 Dec; 14():955. PubMed ID: 25512109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma.
    Zhao P; Lu Y; Jiang X; Li X
    Cancer Sci; 2011 May; 102(5):1107-11. PubMed ID: 21276138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gli1 is a potential cancer stem cell marker and predicts poor prognosis in ductal breast carcinoma.
    Ni W; Yang Z; Qi W; Cui C; Cui Y; Xuan Y
    Hum Pathol; 2017 Nov; 69():38-45. PubMed ID: 28965964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of HOXD13 expression in human breast cancer.
    Zhong ZB; Shan M; Qian C; Liu T; Shi QY; Wang J; Liu Y; Liu Y; Huang YX; Pang D
    Int J Clin Exp Pathol; 2015; 8(9):11407-13. PubMed ID: 26617867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of protein C receptor (PROCR) is associated with inferior clinical outcome in Breast invasive ductal carcinoma.
    Yan Q; Xiaorong Z; Zhang Z; Bing W; Feng Y; Hong B
    Pathol Res Pract; 2017 Sep; 213(9):1173-1179. PubMed ID: 28756987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer.
    Li N; Zheng Y; Xuan C; Lin Z; Piao L; Liu S
    Int J Clin Exp Pathol; 2015; 8(10):12893-900. PubMed ID: 26722481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer.
    Schoppmann SF; Berghoff A; Dinhof C; Jakesz R; Gnant M; Dubsky P; Jesch B; Heinzl H; Birner P
    Breast Cancer Res Treat; 2012 Jul; 134(1):237-44. PubMed ID: 22350732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome.
    Miller P; Kidwell KM; Thomas D; Sabel M; Rae JM; Hayes DF; Hudson BI; El-Ashry D; Lippman ME
    Breast Cancer Res Treat; 2017 Nov; 166(1):85-94. PubMed ID: 28717852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD61+ and CAF+ were found to be good prognosis factors for invasive breast cancer patients.
    Cai D; Wu X; Hong T; Mao Y; Ge X; Hua D
    Pathol Res Pract; 2017 Oct; 213(10):1296-1301. PubMed ID: 28935175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-mobility group box 1 released by autophagic cancer-associated fibroblasts maintains the stemness of luminal breast cancer cells.
    Zhao XL; Lin Y; Jiang J; Tang Z; Yang S; Lu L; Liang Y; Liu X; Tan J; Hu XG; Niu Q; Fu WJ; Yan ZX; Guo DY; Ping YF; Wang JM; Zhang X; Kung HF; Bian XW; Yao XH
    J Pathol; 2017 Nov; 243(3):376-389. PubMed ID: 28802057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and Significance of High-Mobility Group Protein B1 (HMGB1) and the Receptor for Advanced Glycation End-Product (RAGE) in Knee Osteoarthritis.
    Sun XH; Liu Y; Han Y; Wang J
    Med Sci Monit; 2016 Jun; 22():2105-12. PubMed ID: 27320800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenascin C is a prognostic determinant and potential cancer-associated fibroblasts marker for breast ductal carcinoma.
    Yang Z; Ni W; Cui C; Fang L; Xuan Y
    Exp Mol Pathol; 2017 Apr; 102(2):262-267. PubMed ID: 28223108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High fibroblast growth factor 19 (FGF19) expression predicts worse prognosis in invasive ductal carcinoma of breast.
    Buhmeida A; Dallol A; Merdad A; Al-Maghrabi J; Gari MA; Abu-Elmagd MM; Chaudhary AG; Abuzenadah AM; Nedjadi T; Ermiah E; Al-Thubaity F; Al-Qahtani MH
    Tumour Biol; 2014 Mar; 35(3):2817-24. PubMed ID: 24248542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of senescence markers p14(ARF) and p16(INK4a) in breast cancer is associated with an increased risk of disease recurrence and poor survival outcome.
    Pare R; Shin JS; Lee CS
    Histopathology; 2016 Sep; 69(3):479-91. PubMed ID: 26843058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.